Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

14 Feb 2020

Abstract excerpt

Humans are infected with two distinct strains (Type 1 (T1) and Type 2 (T2)) of Epstein-Barr virus (EBV) that differ substantially in their EBNA2 and EBNA 3A/B/C latency genes and the ability to transform B cells in vitro. While most T1 EBV strains contain the "prototype" form of the BZLF1 immediate-early promoter ("Zp-P"), all T2 strains contain the "Zp-V3" variant, which contains an NFAT binding motif and is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32059024
DOI: 10.1371/journal.ppat.1008365

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infectionPMID 32059024Read ↗

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.Semantic proximity Read ↗

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.Semantic proximity Read ↗

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse modelSemantic proximity Read ↗

Latent Membrane Protein 1 and the B Lymphocyte-A Complex RelationshipSemantic proximity Read ↗

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceSemantic proximity Read ↗

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsetsSemantic proximity Read ↗

Evasion of affinity-based selection in germinal centers by Epstein–Barr virus LMP2ASemantic proximity Read ↗

EBV lytic infection enhances transformation of B‐lymphocytes infected with EBV in the presence of T‐lymphocytesSemantic proximity Read ↗

Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB PathwaySemantic proximity Read ↗

Epstein-Barr virus-infected tonsillar marginal zone B cells in vivo as a precursor for immunosuppression-related B-cell lymphomaSemantic proximity Read ↗

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B LymphocytesSemantic proximity Read ↗

LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.